The Impact of Positive Surgical Margins on Mortality Following Radical Prostatectomy During the Prostate Specific Antigen Era

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 1003-1009

  Boorjian, Stephen A ^a   Karnes, R Jeffrey ^b   Crispen, Paul L ^b   Carlson, Rachel E ^b   Rangel, Laureano J ^b   Bergstralh, Eric J ^b   Blute, Michael L ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN SIZE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY;

AGED; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 75849153241     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.11.039     Document Type: Article

References (30)

1. Chang S.S., and Cookson M.S. Impact of positive surgical margins after radical prostatectomy. Urology 68 (2006) 249
2. Eastham J.A., Kattan M.W., Riedel E., et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 170 (2003) 2292
3. Touijer K., Kuroiwa K., Eastham J.A., et al. Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. Eur Urol 52 (2007) 1090
4. Cooperberg M.R., Lubeck D.P., Mehta S.S., et al. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol 170 (2003) S21
5. Epstein J.I. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am 23 (1996) 651
6. Blute M.L., Bostwick D.G., Bergstralh E.J., et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology 50 (1997) 733
7. Grossfeld G.D., Chang J.J., Broering J.M., et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol 163 (2000) 1171
8. Blute M.L., Bergstralh E.J., Iocca A., et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 165 (2001) 119
9. Mann M.J., DeCastro G.J., Desai M., et al. Predictive significance of surgical margin status after prostatectomy for prostate cancer during the PSA era. Urology 72 (2008) 1203
10. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528
11. Swindle P., Eastham J.A., Ohori M., et al. Do margins matter?. The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 174 (2005) 903
12. Karakiewicz P.I., Eastham J.A., Graefen M., et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 66 (2005) 1245
13. Vis A.N., Schröder F.H., and Van der Kwast T.H. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 50 (2006) 258
14. Simon M.A., Kim S., and Soloway M.S. Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. J Urol 175 (2006) 140
15. Eastham J.A., Kuroiwa K., Ohori M., et al. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology 70 (2007) 965
16. Pfitzenmaier J., Pahernik S., Tremmel T., et al. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?. BJU Int 102 (2008) 1413
17. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005
18. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet 366 (2005) 572
19. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 296 (2006) 2329
20. Ward J.F., Blute M.L., Slezak J., et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 170 (2003) 1872
21. Roehl K.A., Han M., Ramos C.G., et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172 (2004) 910
22. Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433
23. Albertsen P.C., Hanley J.A., Gleason D.F., et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280 (1998) 975
24. Bostwick D.G., Myers R.P., and Oesterling J.E. Staging of prostate cancer. Semin Surg Oncol 10 (1994) 60
25. Wieder J.A., and Soloway M.S. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol 160 (1998) 299
26. Trock B.J., Han M., Freedland S.J., et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 299 (2008) 2760
27. Van der Kwast T.H., Bolla M., Van Poppel H., et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 25 (2007) 4178
28. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325
29. Smith Jr. J.A., Chan R.C., Change S.S., et al. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol 178 (2007) 2385
30. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 181 (2009) 956